TOMSK, RUSSIA / RankWire.AI / – Russian scientists have evaluated a bioactive coating aimed at enhancing the interaction between titanium orthopedic implants and bone tissue. The material incorporates calcium phosphate derived from hydroxyapatite and features nitrogen compounds linked to nitric oxide synthesis. Laboratory experiments demonstrated a marked increase in the survival rate of human mesenchymal stem cells on the coated surfaces compared to uncoated titanium. The researchers analyzed the coating’s structure, chemical makeup, mechanical characteristics, and biological response. Their peer-reviewed results appeared in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists produced the experimental coatings through reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen-to-argon ratio during the process to observe how each mixture influenced the resulting surface. Five different conditions were tested, ranging from pure nitrogen to pure argon. The team measured parameters such as coating thickness, surface morphology, hardness, wettability, and chemical composition. They also performed laboratory assessments to observe how living human cells responded to the modified titanium surface.
The study revealed that the argon concentration affected several physical attributes of the coatings. Surfaces created with pure argon were found to be denser and harder than those deposited with pure nitrogen. The coating thickness also increased as the argon proportion grew. Chemical analysis detected nitrogen-carbon and nitrogen-oxygen bonds on the modified surfaces. Subsequently, the team compared the behavior of human mesenchymal stem cells cultivated on coated titanium versus uncoated titanium, focusing on cell viability and markers associated with bone cell differentiation.
Enhanced Cell Survival Observed in Coating Tests
According to the experimental results, cells demonstrated significantly better survival rates on coated surfaces compared to uncoated titanium. After seven days, coatings with higher nitrogen content also appeared to suppress activity in certain genes linked to early bone-cell differentiation. Despite this, the stem cells maintained their capacity for bone formation. These biological responses were evaluated under controlled laboratory conditions using human mesenchymal stem cells. It is important to note that the study did not involve clinical trials or testing of the coatings within patients.
The biomedical evaluation was carried out by researchers from Immanuel Kant Baltic Federal University and Siberian State Medical University. The research team also included specialists from Saint Petersburg State University. The project received funding through Russia’s national science program. The scientists aimed to identify gas mixtures capable of producing coatings with optimal physical, chemical, and biological properties. Hydroxyapatite is already utilized in implant coatings because its calcium phosphate structure closely resembles the mineral component of human bone.
Research Remains in the Laboratory Phase
The research team has planned additional investigations beyond the initial seven-day cell tests. Future studies will examine stem cell responses over periods of 10 to 28 days, as well as assess the rate of coating dissolution and nitric oxide release into surrounding tissue in living organisms. These aspects were not covered by the current laboratory results. Presently, the focus is on coated titanium substrates, their physical and chemical characteristics, and in vitro cellular responses, rather than clinical performance in orthopaedic patients.
The findings offer comprehensive laboratory data on how varying nitrogen and argon ratios influence calcium phosphate coatings on titanium surfaces. Variations in thickness, density, hardness, chemical bonds, and cellular responses across different gas mixtures were documented. The study also confirmed that coated samples supported greater stem-cell survival than uncoated titanium under the experimental conditions. Nonetheless, the research remains at a preclinical stage, and the published experiments do not establish safety or efficacy for human use. Additional biological testing will be necessary to explore properties not addressed in this initial study.